- Home
- TIL vs TRUE Comparison
TIL vs TRUE Comparison
Compare TIL & TRUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | TRUE |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.1M | 193.0M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TIL | TRUE |
|---|---|---|
| Price | $11.32 | $2.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $100.67 | $2.55 |
| AVG Volume (30 Days) | 73.2K | ★ 540.0K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $181,222,000.00 |
| Revenue This Year | N/A | $9.14 |
| Revenue Next Year | N/A | $7.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.18 |
| 52 Week Low | $10.70 | $1.05 |
| 52 Week High | $42.79 | $4.44 |
Technical Indicators
Market Signals| Indicator | TIL | TRUE |
|---|---|---|
| Relative Strength Index (RSI) | 38.95 | 50.31 |
| Support Level | $10.76 | $2.10 |
| Resistance Level | $11.51 | $2.22 |
| Average True Range (ATR) | 0.88 | 0.07 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 24.64 | 64.71 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.